Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jns.2020.116883 http://scihub22266oqcxt.onion/10.1016/j.jns.2020.116883 32413768!7202820!32413768     free     free     free       J+Neurol+Sci 2020 ; 414 (?): 116883 Nephropedia Template TP {{tp|p=32413768|t=2020. Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients |pdf=|usr=}}{{32413768}} gab.com Text Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients JO: J Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=32413768 #FOAvip ? Twit Text FOAVip Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients ????J Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=32413768 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32413768 #FOAvip English Wikipedia <ref>{{Cite pmid|32413768}}</ref> Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients #MMPMID32413768 Lee M; Chen CS; Ovbiagele B J Neurol Sci 2020[Jul]; 414 (?): 116883 PMID32413768show ga ? |*Betacoronavirus[MESH] |*Coronavirus Infections/complications[MESH] |*Delivery of Health Care[MESH] |*Evidence-Based Pharmacy Practice/methods/organization & administration[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/complications[MESH] |Anticoagulants/supply & distribution/therapeutic use[MESH] |Atrial Fibrillation/complications/drug therapy[MESH] |COVID-19[MESH] |Cardiovascular Agents/supply & distribution/*therapeutic use[MESH] |Drug Monitoring[MESH] |Humans[MESH] |Medication Adherence[MESH] |Medication Systems/organization & administration[MESH] |Quarantine[MESH] |Recurrence[MESH] |SARS-CoV-2[MESH] |Secondary Prevention[MESH]Covert COVID-19 complications: Continuing the use of evidence-based dr(epmc).pdf DeepDyve Pubget Overpricing